"It's not just taking something away, but really doing a careful assessment of how that medication works within that ...

CHICAGO -- A once-weekly basal insulin had similar safety and efficacy to a daily insulin option, a series of trials from the ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

Prior authorization varies by plan but often requires patients or their providers to get permission (also called ...

CHICAGO -- An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with ...

CHICAGO -- An investigational allogeneic stem cell-derived islet-cell therapy helped almost all patients with type 1 diabetes ...

The interview, which was conducted with a public relations person present, has been edited for length and clarity. Many ...

Over a median follow-up of 7 years, breast cancer survivors had an 8% lower risk of Alzheimer's dementia compared with ...

Manav Midha is an MD candidate at the Icahn School of Medicine at Mount Sinai and a researcher at the USC Schaeffer Center ...

HHS Secretary Robert F. Kennedy Jr. said in April that he plans to tell medical schools to teach nutrition or risk losing ...

The FDA approved dupilumab (Dupixent) as the first targeted drug for bullous pemphigoid, a rare blistering skin disease that ...